X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (134705) 134705
Newspaper Article (17130) 17130
Publication (11280) 11280
Newsletter (9398) 9398
Book Review (1438) 1438
Trade Publication Article (891) 891
Book Chapter (718) 718
Magazine Article (656) 656
Web Resource (410) 410
Book / eBook (248) 248
Conference Proceeding (215) 215
Dissertation (99) 99
Transcript (45) 45
Government Document (42) 42
Report (30) 30
Data Set (18) 18
Reference (16) 16
Streaming Video (11) 11
Paper (6) 6
Presentation (2) 2
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (105692) 105692
leukemia (55742) 55742
index medicus (48588) 48588
oncology (45457) 45457
male (45132) 45132
female (44402) 44402
cancer (37277) 37277
hematology (35847) 35847
adult (28632) 28632
middle aged (27996) 27996
animals (26938) 26938
aged (20614) 20614
chemotherapy (19530) 19530
research (19146) 19146
adolescent (17741) 17741
child (17177) 17177
mice (16998) 16998
apoptosis (15958) 15958
antineoplastic agents - therapeutic use (15746) 15746
care and treatment (15154) 15154
antineoplastic combined chemotherapy protocols - therapeutic use (13145) 13145
acute myeloid-leukemia (11813) 11813
treatment outcome (11715) 11715
child, preschool (10992) 10992
therapy (10666) 10666
prognosis (10637) 10637
cell line, tumor (10454) 10454
leukemia, myeloid, acute - drug therapy (10213) 10213
antineoplastic agents - pharmacology (10149) 10149
cancer therapies (9858) 9858
drug therapy (9574) 9574
pharmacology & pharmacy (9394) 9394
acute lymphoblastic-leukemia (9215) 9215
health aspects (9198) 9198
apoptosis - drug effects (8561) 8561
analysis (8439) 8439
lymphomas (8393) 8393
stem cells (8272) 8272
expression (8202) 8202
oncology, experimental (8176) 8176
leukemia - drug therapy (8107) 8107
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (7950) 7950
transplantation (7896) 7896
patients (7604) 7604
clinical trials (7584) 7584
tumors (7527) 7527
pediatrics (7517) 7517
proteins (7418) 7418
mutation (7417) 7417
genetic aspects (7200) 7200
cell biology (6921) 6921
antineoplastic agents (6879) 6879
remission induction (6840) 6840
immunology (6784) 6784
risk factors (6727) 6727
biochemistry & molecular biology (6696) 6696
medical research (6606) 6606
acute disease (6581) 6581
children (6560) 6560
bone marrow (6533) 6533
infant (6529) 6529
gene expression (6488) 6488
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (6408) 6408
chronic myeloid leukemia (6325) 6325
article (6295) 6295
aged, 80 and over (6242) 6242
chronic lymphocytic-leukemia (6002) 6002
antineoplastic agents - adverse effects (5962) 5962
dose-response relationship, drug (5923) 5923
antimitotic agents (5910) 5910
time factors (5864) 5864
tumor cells, cultured (5645) 5645
drug resistance (5619) 5619
neoplasms - drug therapy (5603) 5603
hemic and lymphatic diseases (5602) 5602
kinases (5550) 5550
chronic myelogenous leukemia (5549) 5549
imatinib mesylate (5443) 5443
immunotherapy (5311) 5311
medicine & public health (5270) 5270
retrospective studies (5218) 5218
cells (5215) 5215
medicine (5196) 5196
chronic myeloid-leukemia (5186) 5186
pharmaceutical industry (5181) 5181
acute myeloid leukemia (5118) 5118
survival (4978) 4978
young adult (4870) 4870
hematology, oncology and palliative medicine (4846) 4846
drugs (4839) 4839
medicine, research & experimental (4774) 4774
acute lymphocytic leukemia (4744) 4744
in-vitro (4616) 4616
studies (4569) 4569
recurrence (4555) 4555
flow cytometry (4454) 4454
leukemia, lymphoid - drug therapy (4445) 4445
cell proliferation - drug effects (4443) 4443
signal transduction (4429) 4429
antineoplastic agents - administration & dosage (4372) 4372
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (171) 171
Online Resources - Online (29) 29
Collection Dvlpm't (Acquisitions) - Vendor file (23) 23
Collection Dvlpm't (Acquisitions) - Closed Orders (10) 10
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (9) 9
UofT at Mississauga - Stacks (6) 6
St. Michael's College (John M. Kelly) - 2nd Floor (5) 5
UTL at Downsview - May be requested (5) 5
UofT at Scarborough - Stacks (4) 4
Robarts - Stacks (3) 3
University College (Laidlaw) - Stacks (3) 3
Credit Valley Hospital - Stacks (2) 2
New College (Ivey) - Stacks (2) 2
Thomas Fisher Rare Book - Rare Book (2) 2
Baycrest Hospital - Resident/Client Library (1) 1
Baycrest Hospital - Wellness Library (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Media Commons - Audio Visual (1) 1
OISE - Curriculum Resources (1) 1
OISE - Stacks (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
Toronto East General Hospital - Stacks (1) 1
Trinity College (John W Graham) - Stacks (1) 1
Trinity College (John W Graham) - Storage (1) 1
UofT Schools - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (154032) 154032
Japanese (2150) 2150
German (1722) 1722
French (1371) 1371
Russian (1104) 1104
Chinese (1064) 1064
Spanish (674) 674
Polish (548) 548
Italian (489) 489
Czech (124) 124
Hungarian (116) 116
Portuguese (87) 87
Dutch (82) 82
Danish (80) 80
Norwegian (79) 79
Swedish (60) 60
Korean (45) 45
Hebrew (42) 42
Croatian (39) 39
Serbian (38) 38
Romanian (34) 34
Turkish (30) 30
Slovak (24) 24
Finnish (23) 23
Ukrainian (12) 12
Bulgarian (9) 9
Arabic (6) 6
Persian (5) 5
Afrikaans (3) 3
Slovenian (3) 3
Urdu (3) 3
Bosnian (2) 2
Catalan (1) 1
Greek (1) 1
Lithuanian (1) 1
Thai (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


NEW ENGLAND JOURNAL OF MEDICINE, ISSN 0028-4793, 03/2004, Volume 350, Issue 10, pp. 1013 - 1022
  The single most common cause of the withdrawal or restriction of the use of marketed drugs has been QT-interval prolongation associated with polymorphic... 
ANTIARRHYTHMIC DRUGS | MEDICINE, GENERAL & INTERNAL | TORSADES-DE-POINTES | TRIGGERED ACTIVITY | CARDIAC-ARRHYTHMIA | M-CELLS | CLINICAL-FEATURES | VENTRICULAR ARRHYTHMIAS | ACUTE PROMYELOCYTIC LEUKEMIA | POTASSIUM CHANNEL | ATRIAL-FIBRILLATION | Side effects | Drug therapy | Health risk assessment | Toxicity | Decision making
Journal Article
Annual Review of Pharmacology and Toxicology, ISSN 0362-1642, 2001, Volume 41, Issue 1, pp. 101 - 121
Journal Article
Leukemia, ISSN 0887-6924, 08/2011, Volume 25, Issue 8, pp. 1314 - 1323
The bone marrow (BM) stromal niche can protect acute lymphoblastic leukemia (ALL) cells against the cytotoxicity of chemotherapeutic agents and is a possible... 
SDF-1α | Ph ALL | leukemia cell mobilization | AMD3100 | stromal co-culture | AMD11070 | CHEMOKINE RECEPTOR CXCR4 | BONE-MARROW | Ph plus ALL | GROWTH-STIMULATING FACTOR | FACTOR-I | CHRONIC MYELOID-LEUKEMIA | HEMATOPOIETIC PROGENITOR CELLS | ONCOLOGY | PHILADELPHIA-CHROMOSOME | IMATINIB | PRECURSOR-B | STROMAL CELLS | HEMATOLOGY | SDF-1 alpha | Heterocyclic Compounds - administration & dosage | Receptors, CXCR4 - antagonists & inhibitors | Humans | Mice, Inbred C57BL | Aminoquinolines - administration & dosage | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Aminoquinolines - metabolism | Heterocyclic Compounds, 1-Ring | Chemokine CXCL12 - antagonists & inhibitors | Cell Movement - drug effects | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Animals | Benzimidazoles - administration & dosage | Signal Transduction - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Benzimidazoles - metabolism | Vincristine - administration & dosage | Mice | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Antagonists (Biochemistry) | Antimitotic agents | Demographic aspects | Patient outcomes | Dosage and administration | Research | Drug therapy, Combination | Acute lymphocytic leukemia | Antineoplastic agents | Drug therapy | Index Medicus | Ph-positive ALL
Journal Article